Vertex Pharmaceuticals Inc (NASDAQ:VRTX)
| 347.66 Delayed Data As of Sep 29 |  -4.84 / -1.37%Today’s Change | 282.21 Today|||52-Week Range 367.00 | +20.39% Year-to-Date |
Latest VRTX News | Press Releases
| 3 Revolutionary Stocks I'd Buy Right Now Without Hesitation Oct 01 / MotleyFool.com - Paid Partner Content | Is It Worth Investing in Vertex (VRTX) Based on Wall Street's Bullish Views? Sep 29 / Zacks.com - Paid Partner Content |
| 2 Brilliant Growth Stocks to Invest $2,000 in Right Now Oct 01 / MotleyFool.com - Paid Partner Content | Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now? Sep 29 / Zacks.com - Paid Partner Content |
| 5 Top Stocks for October Oct 01 / MotleyFool.com - Paid Partner Content | Vertex Pharmaceuticals (VRTX) Gains But Lags Market: What You Should Know Sep 25 / Zacks.com - Paid Partner Content |
| The Best Stocks to Invest $5,000 in Right Now Sep 30 / MotleyFool.com - Paid Partner Content | Buying These 2 Remarkable Growth Stocks in Any Market Could Be a Genius Move Sep 25 / MotleyFool.com - Paid Partner Content |
| Why Editas Medicine Stock Is Soaring Today Sep 29 / MotleyFool.com - Paid Partner Content | 3 Magnificent Growth Stocks to Buy Right Now Sep 24 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 352.50 |
| Today’s open | 352.80 |
| Day’s range | 347.39 - 354.05 |
| Volume | 27,598 |
| Average volume (3 months) | 1,129,932 |
| Market cap | $89.7B |
Data as of 4:00pm ET, 09/29/2023
Growth & Valuation
| Earnings growth (last year) | +42.72% |
| Earnings growth (this year) | -2.24% |
| Earnings growth (next 5 years) | +12.00% |
| Revenue growth (last year) | +15.04% |
| P/E ratio | 26.9 |
| Price/Sales | 8.55 |
| Price/Book | 6.42 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| REGNRegeneron Pharmaceut... | -11.30 | -1.35% |
| ZTSZoetis Inc | -0.09 | -0.05% |
| ---- | ||
| GSKGlaxoSmithKline | -0.08 | -0.22% |
Data as of 4:00pm ET, 09/29/2023
Financials
| Next reporting date | November 1, 2023 |
| EPS forecast (this quarter) | $3.88 |
| Annual revenue (last year) | $8.7B |
| Annual profit (last year) | $3.3B |
| Net profit margin | 37.97% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Boston, Massachusetts |
Forecasts
